The scientific community is inviting anyone to submit abstracts for the Fourth Abu Dhabi Pharmacy Conference. Abstracts submissions are accepted until the 15th of April, 2019 (12 AM Dubai time +4 GMT). Any abstract received after the deadline will not be accepted. Upon completion of the evaluation by the Scientific Committee an ‘Accepted’ or ‘Rejected’ email will be sent to each application submitted. Acceptance or rejection letters will be will be sent approximately 7 days after deadline submission.

Language:

• All submitted abstracts must be in English

Author(s):

• The content of the abstract is solely the responsibility of the author. The original abstract is reprinted exactly as provided. During submission, it must clearly indicate the name of the presenting author, who will be considered the contact person for all correspondence connected with the submitted abstract.
• All submitted abstracts need to have the names and surnames of all co-authors, along with their positions in their affiliated institutions.

Length:

• The limit for the poster abstract is 2800 characters. If tables are included, each table removes 320 characters from your character limit.

Title:

• A poster abstract must have a short, specific title (no abbreviations) that clearly indicates the nature of the investigation. It is encouraged that the title is set so as to attract the audience and to hint to the conclusion of the investigation.

Content:

• A well-written poster abstract typically has the following identified sections:
  1. Background/objectives: a brief introduction, which states the problem that you are addressing as well as some background information on the issue. The introduction of the poster abstract should include a very brief background 1-2 statements followed by the objectives of the investigation.
  2. Design and methods: the methodologies, number of test subjects and scientific approach used to conduct the research.
  3. Results: it is expected that authors present data that support their conclusion. Tables and graphs should include explanatory captions.
  4. Conclusions: further areas of research and overall conclusion of the research
  5. Citation: a reference list and acknowledgements, if applicable

Tips in writing your poster:

• Make the title dynamic and conclusive, rather than descriptive.
• Identify your submission category carefully to assure proper consideration.
• Use generic names. Use trade names only when necessary.
• Avoid beginning sentences with numerals.
• Standard abbreviations may be used without definition. Nonstandard abbreviations should be placed in parentheses after the first use of the word or phrase abbreviated.
• No references, credits or grant support should be included in the poster abstract.
• No identifying information about patients participating in a study or trial should be used.
• All abbreviations must be defined before being used as an abbreviation in the text.
• Proofread poster abstracts carefully to avoid errors before submission. No corrections will be allowed or made once the poster abstract has been submitted.

The submitting author must verify that all co-authors have read and approved the submission of the poster abstract.

A disclosure form identifying commercial relationships for all co-authors must be completed by the submitting author, if their poster abstract has been accepted for publication. The submitting author signs and verifies disclosure on behalf of all co-authors. Disclosure information for accepted poster abstracts will be made available to the meeting attendees.

Upon completion of the evaluation of submitted abstracts, an ‘Accepted’ or ‘Rejected’ email will be sent to authors. Upon acceptance of an author’s poster presentation, the following instructions below are applicable:

• The presenting author of the poster presentation should confirm their attendance upon receiving the acceptance email within one week.
• The availability of any sort of grant for registration, travel and/or accommodation will be mentioned in the acceptance email, without any guarantees at the abstract submission stage.
• Poster authors who confirm presence will receive a poster code based on their category of submission 1 week before the conference. Authors should use the poster code in that email to find their space at the poster area during the conference.
• Authors need to place the title, author(s), institution if applicable and country at the header of the poster presentation
• The poster display board dimensions will be 91 CM wide x 151 CM length. All posters need to be constraint to that size and not more. Please download the template for more insight.
• The poster thickness of paper advised is 120 to 150 gsm
• The boards are made out of cork and posters will be pinned or applied using double-sided taped
• Presenting authors should mount their poster in the allocated poster display area before the conference lectures initiate, during registration time in the early morning
• Posters should be left on display during the conference until end of the conference
• Authors should be available near their posters particularly during allotted timings that will be stated in the acceptance email.